What is Achyut Healthcare share price return in the past 10 years?

Data is not available for this company

Achyut Healthcare Ltd - Stock Valuation and Financial Performance

Name: Achyut Healthcare
Brand: Achyut Healthcare

BSE: 543499 | NSE: | Trading | Small Cap

Place order

Achyut Healthcare Share Price

₹50.80 0.00 0.00%
as on 16-Apr'24 16:01

DeciZen - make an informed investing decision on Achyut Healthcare

Based on:

Data

M-Cap below 100cr DeciZen not available

Achyut Healthcare stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

369.70

Market Cap:

85.5 Cr.

52-wk low:

34.4

52-wk high:

60.8

Is Achyut Healthcare Ltd an attractive stock to invest in?

1. Is Achyut Healthcare Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Achyut Healthcare Ltd is a below average quality company.

2. Is Achyut Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Achyut Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Achyut Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Achyut Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Achyut Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-7.2%	3.3%	4.6%	0.9%	2%	-
Value Creation Index ⓘ	-1.5	-0.8	-0.7	-0.9	-0.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.7	0.3	0.3	4.1	2.7	3
Sales YoY Gr.	-	-50.8%	-18.2%	1,400%	-33.3%	-
Adj EPS ⓘ	-0.2	0.1	0.2	0	0.2	0.1
YoY Gr.	-	NA	66.7%	-73.3%	325%	-
BVPS (₹) ⓘ	2.8	2.9	3.5	9	10.4	20.8
Adj Net Profit ⓘ	0	0	0	0	0.2	0
Cash Flow from Ops. ⓘ	0	0	0	-7	-0.4	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	101.5%	-33.3%
Adj EPS ⓘ	NA	NA	23.6%	325%
BVPSⓘ	NA	NA	52.2%	15.4%
Share Price	-	-	-	-6.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-7.5	3.2	4.6	0.9	2	0.9
Op. Profit Mgn % ⓘ	2.1	2.3	4.2	-1	-10.1	NAN
Net Profit Mgn % ⓘ	-2.2	2	3.9	1	8.6	8.7
Debt to Equity ⓘ	0	0	0	0	0	-
Working Cap Days ⓘ	0	248	470	378	1,233	0
Cash Conv. Cycle ⓘ	0	105	215	2	15	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 101.50%

Net Profit is growing at healthy rate in last 3 years 23.61%

Return on Equity has declined versus last 3 years average to 0.90%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Achyut Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.1	-
TTM Sales (₹ Cr.)	2.7	-
BVPS (₹.) ⓘ	20.8	-
Reserves (₹ Cr.) ⓘ	18	-
P/BV ⓘ	2.45	-
PE ⓘ	369.70	-

From the Market
52 Week Low / High (₹)	34.39 / 60.79
All Time Low / High (₹)	10.00 / 60.79
Market Cap (₹ Cr.)	85.5
Equity (₹ Cr.)	16.8
Face Value (₹)	10
Industry PE ⓘ	75.9

Management X-Ray of Achyut Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Achyut Healthcare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Achyut Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0.67	0.33	0.27	4.05	2.70
Operating Expenses ⓘ	0.65	0.33	0.26	4.09	2.97
Manufacturing Costs	0	0.05	0	0	0
Material Costs	0.55	0.18	0.23	3.32	1.96
Employee Cost	0.01	0.01	0	0.04	0.07
Other Costs ⓘ	0.09	0.09	0.03	0.73	0.94
Operating Profit ⓘ	0.01	0.01	0.01	-0.04	-0.27
Operating Profit Margin (%)	2.1%	2.3%	4.1%	-0.9%	-10.2%
Other Income ⓘ	0	0.01	0	0.14	0.59
Interest ⓘ	0	0	0	0	0
Depreciation ⓘ	0	0	0	0.01	0.01
Exceptional Items ⓘ	0	0	0	0	0
Profit Before Tax ⓘ	0.01	0.02	0.01	0.10	0.31
Tax ⓘ	0.03	0	0	0.06	0.08
Profit After Tax	-0.01	0.01	0.01	0.04	0.23
PAT Margin (%)	-2.2%	4.2%	3.9%	1.0%	8.6%
Adjusted EPS (₹)	-0.2	0.2	0.2	0.0	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	0.20	0.21	0.25	9.08	14.52
Share Capital ⓘ	0.25	0.25	0.25	6.74	9.35
Reserves ⓘ	-0.05	-0.04	0	2.34	5.18
Minority Interest	0	0	0	0	0
Debt	0	0	0	0	0
Long Term Debt	0	0	0	0	0
Short Term Debt	0	0	0	0	0
Trade Payables	0.02	0.05	0.24	0.38	0.30
Others Liabilities ⓘ	0.01	0.01	-0.02	0.48	0.51
Total Liabilities ⓘ	0.23	0.27	0.47	9.94	15.34
Fixed Assets
Gross Block	0	0	0	0.03	0.06
Accumulated Depreciation	0	0	0	0.01	0.01
Net Fixed Assetsⓘ	0	0	0	0.03	0.05
CWIP ⓘ	0	0	0	0	3.49
Investmentsⓘ	0	0	0	1.70	1.30
Inventories	0	0	0.10	0.13	0.32
Trade Receivables	0.10	0.17	0.28	0.20	0.27
Cash Equivalents	0.04	0.01	0.02	0.26	0.23
Others Assetsⓘ	0.10	0.09	0.07	7.62	9.67
Total Assets ⓘ	0.23	0.27	0.47	9.94	15.34

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.03	-0.02	-6.96	-0.43
PBT ⓘ	0.01	0.02	0.10	0.31
Adjustment ⓘ	-0.01	0	-0.13	-0.57
Changes in Working Capital ⓘ	-0.03	-0.03	-6.9	-0.08
Tax Paid ⓘ	0	-0.01	-0.03	-0.09
Cash Flow From Investing Activity ⓘ	0	0	-1.60	-4.81
Capex	0	0	-0.03	-3.32
Net Investments	0	0	-1.70	-2.76
Others ⓘ	0	0	0.14	1.27
Cash Flow From Financing Activityⓘ	0	0	8.79	5.21
Net Proceeds from Shares ⓘ	0	0	8.79	5.21
Net Proceeds from Borrowing ⓘ	0	0	0	0
Interest Paid ⓘ	0	0	0	0
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	0	0	0	0
Net Cash Flow ⓘ	-0.03	-0.02	0.24	-0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-7.46	6.91	4.62	0.86	1.96
ROCE (%)	7.21	9.48	5.61	2.17	2.64
Asset Turnover Ratio	2.89	1.33	0.74	0.78	0.21
PAT to CFO Conversion(x)	N/A	-2	0	-174	-1.87
Working Capital Days
Receivable Days	53	146	301	21	32
Inventory Days	0	0	128	10	30
Payable Days	16	71	225	34	64

Achyut Healthcare Ltd Stock News

Achyut Healthcare Ltd FAQs

What is the share price of Achyut Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of Achyut Healthcare on 16-Apr-2024 16:01 is ₹50.80.

What is the market cap of Achyut Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2024 16:01 the market cap of Achyut Healthcare stood at ₹85.47.

What is the P/E ratio of Achyut Healthcare?

The latest P/E ratio of Achyut Healthcare as of 16-Apr-2024 16:01 is 369.7.

What is the P/B ratio of Achyut Healthcare?

The latest P/B ratio of Achyut Healthcare as of 16-Apr-2024 16:01 is 2.45.

What is the 52-week high and low of Achyut Healthcare?

The 52-week high of Achyut Healthcare is ₹60.79 and the 52-week low is ₹34.39.

What is the TTM revenue of Achyut Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Achyut Healthcare is ₹2.70 ( Cr.) .

About Achyut Healthcare Ltd

Achyut Healthcare is engaged in the trading of Pharmaceutical Products. The company has business operations in both domestic and international markets in the countries namely UAE, Kenya, and Nigeria. The company is located in Ahmedabad, Gujarat. Since incorporation, it was the company‘s vision and mission has been to remained focused towards the pharmaceutical business of trading and supplying of superior quality products to its customers based on their customizations and requirements, which has enabled it to expand its business operations globally and dive into manufacturing business on its own plants rather than outsourcing and procuring from third parties.

Business area of the company

The company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Major Events and Milestones

January 11, 1996: The company was incorporated as a private limited company.
October 21, 2002: The name of Company was changed from ‘Achyut Securities Private Limited’ to ‘Achyut Healthcare Private Limited’.
November 30, 2021: The Company was converted into a public limited company.